Life Science REIT PLC (LABS) — Capital Reinvestment Ratio
Latest as of June 2025:
6.06x
Life Science REIT PLC (LABS) has a Capital Reinvestment Ratio of 6.06x as of June 2025, meaning it reinvests 6% of its operating cash flow (GBX958.00K) in capital expenditures (GBX5.81 Million). See Life Science REIT PLC (LABS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
6.06x
Capex / Operating Cash Flow
Operating Cash Flow
GBX958.00K
GBX
Capital Expenditures
GBX5.81 Million
GBX
Data as of
Jun 2025
Most recent filing
Life Science REIT PLC Capital Reinvestment Ratio (2021–2024)
This chart tracks Life Science REIT PLC's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Life Science REIT PLC (2021–2024)
Year-by-year Capital Reinvestment Ratio for Life Science REIT PLC from 2021 to 2024. For live market cap and broader valuation context, see market cap of Life Science REIT PLC.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.49x | GBX12.92 Million | GBX19.28 Million | ▼ -52.7% |
| 2023 | 3.16x | GBX7.62 Million | GBX24.03 Million | ▲ +46.1% |
| 2021 | 2.16x | GBX3.54 Million | GBX7.64 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow